SYNTHESIS OF GLYCOSAMINOGLYCANS

Information

  • Research Project
  • 8764549
  • ApplicationId
    8764549
  • Core Project Number
    N43CA000000
  • Full Project Number
    261201300049C-0-0-1
  • Serial Number
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/12/2013 - 11 years ago
  • Project End Date
    6/11/2014 - 10 years ago
  • Program Officer Name
  • Budget Start Date
    -
  • Budget End Date
    -
  • Fiscal Year
    2013
  • Support Year
  • Suffix
  • Award Notice Date
    -

SYNTHESIS OF GLYCOSAMINOGLYCANS

The glycosaminoglycan (GAG) class of carbohydrates is characterized by unparalleled sequence diversity. Located on the cell surface and in the extracellular matrix, specific structural features are required for a variety of functions including coagulation, cell-signaling and wound healing among others. One limitation to elucidating detailed structure-function relationships between GAGs and their binding partners is the absence of significant quantities of chemically pure GAG oligosaccharides. The aims of this project are to: ¿ Provide an initial library oftetra-, hexa- and octasaccharide GAG sequences ¿ Develop a flexible synthetic strategy for producing multiple oligosaccharides from a single intermediate (Intermediate is defined as a chemical entity produced en route to a final product. In this case, the contractor plans to produce GAG building blocks, which shall be modified in such a way as to generate more advanced chemical entities (intermediates), each of which can be used to produce multiple final products in the target library). ¿ Produce large quantities of GAG building blocks for use in the current proposal and in future libraries

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    N43
  • Administering IC
    CA
  • Application Type
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    299248
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    396
  • Ed Inst. Type
  • Funding ICs
    NCI:299248\
  • Funding Mechanism
    SBIR/STTR Contracts
  • Study Section
  • Study Section Name
  • Organization Name
    ANCORA PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
    130452118
  • Organization City
    MEDFORD
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    021554243
  • Organization District
    UNITED STATES